Vivimed Labs reports consolidated net loss of Rs 27.46 crore in the March 2021 quarter

Last Updated : Jun 29 2021 | 9:06 AM IST

Sales decline 83.47% to Rs 38.99 crore

Net Loss of Vivimed Labs reported to Rs 27.46 crore in the quarter ended March 2021 as against net loss of Rs 60.84 crore during the previous quarter ended March 2020. Sales declined 83.47% to Rs 38.99 crore in the quarter ended March 2021 as against Rs 235.82 crore during the previous quarter ended March 2020.

For the full year,net loss reported to Rs 77.80 crore in the year ended March 2021 as against net loss of Rs 109.12 crore during the previous year ended March 2020. Sales declined 18.64% to Rs 861.47 crore in the year ended March 2021 as against Rs 1058.80 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales38.99235.82 -83 861.471058.80 -19 OPM %-41.91-8.76 -2.760.77 - PBDT-23.77-32.96 28 -20.27-42.53 52 PBT-27.90-50.44 45 -75.77-109.47 31 NP-27.46-60.84 55 -77.80-109.12 29

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Jun 29 2021 | 8:08 AM IST

Explore News

Stock Market Updates World Heart Day 2023 Asian Games 2023 Kabaddi schedule Latest News Live Asian Games LIVE updates India Cricket World Cup Squad Hookah Ban in Haryana Gold-Silver Price MCX Share Price Asian Games 2023 September 30 schedule

Companies News

Air India completes acquisition of its 1st A350 aircraft through GIFT City Jalan Kalrock Consortium infuses Rs 100 crore in cash-strapped Jet Airways

Sports News

Asian Games 2023 September 30 schedule: India event timings, streaming Asian Games Day 6 Highlights: Historic shot put medal push IND tally to 33

India News

Punjab farmers continue three-day 'rail roko' agitation over MSP demand War in Ukraine pushes India to obtain more self-propelled guns to arsenal

Economy News

Adani partnership remains steadfast: IHC on Adani units' stake sale Sugar market eyes restrictions from India after lower monsoon rains

Vivimed Labs reports consolidated net loss of Rs 27.46 crore in the March 2021 quarter

Also Read

Vivimed Labs hits the roof after Govt nod for Favipiravir

Vivimed Labs soars after Jeedimetla facility gets Ukraine GMP approval

Vivimed Labs gains on regulatory approval for two products

Vivimed Labs soars on regulatory nod for three products

Vivimed Labs receives Ukraine GMP approval for Jeedimetla facility

Panache Innovations reports consolidated net profit of Rs 0.17 crore in the March 2021 quarter

Vedavaag Systems consolidated net profit rises 494.12% in the March 2021 quarter

Ganodaya Finlease reports consolidated net profit of Rs 2.42 crore in the March 2021 quarter

Omansh Enterprises reports standalone net profit of Rs 0.15 crore in the March 2021 quarter

Welspun Corp standalone net profit rises 223.05% in the March 2021 quarter

Explore News